BioRecilGent (B)
The case focuses on the development of a yet-to-be-approved drug. It presents the various options open to the company developing the drug in the context of the phases that the medicine must go through to be approved.
Collection: IESE (España)
Ref: AD-381-E
Format: PDF
Number of pages: 1
Publication Date: Apr 4, 2022
What material is included in this case:
Description
The case focuses on the development of a yet-to-be-approved drug. It presents the various options open to the company developing the drug in the context of the phases that the medicine must go through to be approved.
Read more
Geographic Setting: Spain
Industry Setting: Health
Learning Objective
The case can be used to introduce students to decision trees and financing methods for a newly launched company.
Leave your rating
"BioRecilGent (B)"
Register for free with IESE Publishing and enjoy all the advantages
What type of account do you want to create?
Choose account type
Professors
Academic Institutions
Companies
Individuals